...
机译:循环肿瘤DNA以预测新辅助校长后的外科结果,用于临界可重症/局部晚期胰腺癌
Harvard Radiat Oncol Program Boston MA USA;
Massachusetts Gen Hosp Boston MA 02114 USA;
Massachusetts Gen Hosp Boston MA 02114 USA;
Massachusetts Gen Hosp Ctr Biostat Boston MA 02114 USA;
Massachusetts Gen Hosp Boston MA 02114 USA;
Massachusetts Gen Hosp Boston MA 02114 USA;
Massachusetts Gen Hosp Dept Pathol Boston MA 02114 USA;
Massachusetts Gen Hosp Boston MA 02114 USA;
Massachusetts Gen Hosp Boston MA 02114 USA;
Massachusetts Gen Hosp Boston MA 02114 USA;
Massachusetts Gen Hosp Boston MA 02114 USA;
Massachusetts Gen Hosp Boston MA 02114 USA;
Massachusetts Gen Hosp Boston MA 02114 USA;
Massachusetts Gen Hosp Boston MA 02114 USA;
Massachusetts Gen Hosp Boston MA 02114 USA;
Massachusetts Gen Hosp Dept Radiat Oncol Boston MA 02114 USA;
Massachusetts Gen Hosp Boston MA 02114 USA;
Massachusetts Gen Hosp Boston MA 02114 USA;
Massachusetts Gen Hosp Ctr Canc Boston MA USA;
Massachusetts Gen Hosp Dept Radiat Oncol Boston MA 02114 USA;
机译:循环肿瘤DNA以预测新辅助校长后的外科结果,用于临界可重症/局部晚期胰腺癌
机译:邻近诱导化疗和新辅助立体定向体放射治疗的临界和局部晚期胰腺癌病理肿瘤反应等级的预测因子和生存
机译:在新辅助化疗后剩下的局部晚期(边缘可重型和不可切除)胰腺癌的疗效尤为胃癌
机译:预处理DCE MRI的纹理动力学特征可预测直肠癌新辅助化学放疗后病理性肿瘤分期
机译:针对边缘可切除胰腺癌病变的VMAT,IMRT和质子治疗技术的剂量学评估
机译:网络荟萃分析比较可切除边缘可切除和局部晚期胰腺导管腺癌患者的新辅助放化疗新辅助化疗和前期手术
机译:临床切除和局部晚期胰腺癌病理肿瘤反应等级的预测因子和生存率,诱导化疗和新辅助立体定向体放射治疗